# Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms

> **NCT07484412** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Seoul National University Bundang Hospital** · enrollment: 88 (estimated)

## Conditions studied

- Lower Abdominal Pain
- Diarrhea
- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Bifidobacterium longum BBH016
- **DIETARY_SUPPLEMENT:** Placebo Capsule(s)

## Key facts

- **NCT ID:** NCT07484412
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-02-24
- **Final completion:** 2026-12-31
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07484412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07484412, "Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07484412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*